About the PI
I am fascinated by the molecular creativity viruses use to recognize, enter and hijack cells. My mission is to understand and inhibit these molecular processes by combining tools of computational and experimental methods - with the goal to develop new avenues for diagnostics, therapeutics and vaccines.
The Foresight Institute made a short interview video clip during the 2017 AI workshop containing parts of my vision (in 1 min).
During my a post-doctoral training in Dr. David Baker’s lab (University of Washington), I developed both experimental and computational methods for designing proteins and protein-protein interactions. Using these, I have been working on generating molecular tools, such as pH-dependent antibody binding and ways to detect and inhibit viruses, primarily focusing on Influenza.
I received my Ph.D from the Chemistry/Biochemistry Department at the University of Texas at Austin under the supervision of Dr. George Georgiou where I used directed evolution principles to explore microbial physiology, and also to develop new, biotechnologically relevant, genetic screens.
I am fascinated by the molecular creativity viruses use to recognize, enter and hijack cells. My mission is to understand and inhibit these molecular processes by combining tools of computational and experimental methods - with the goal to develop new avenues for diagnostics, therapeutics and vaccines.
The Foresight Institute made a short interview video clip during the 2017 AI workshop containing parts of my vision (in 1 min).
During my a post-doctoral training in Dr. David Baker’s lab (University of Washington), I developed both experimental and computational methods for designing proteins and protein-protein interactions. Using these, I have been working on generating molecular tools, such as pH-dependent antibody binding and ways to detect and inhibit viruses, primarily focusing on Influenza.
I received my Ph.D from the Chemistry/Biochemistry Department at the University of Texas at Austin under the supervision of Dr. George Georgiou where I used directed evolution principles to explore microbial physiology, and also to develop new, biotechnologically relevant, genetic screens.